FarFaR - Pharmacy Repository
University of Belgrade, Faculty of Pharmacy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Eikozanoidi u terapiji astme

Thumbnail
2002
375.pdf (385.9Kb)
Authors
Vladimirov, Sote
Agbaba, Danica
Article (Published version)
Metadata
Show full item record
Abstract
Many novel types of asthma therapeutic procedures have been investigated in the past decade. A vast amount of work in the 5-LO inhibitor and LT1-receptor antagonist area has resulted in a various of compounds being identified for clinical trails, and several compounds are used in the clinic. The impact of the LT1-receptor antagonist and 5-LO inhibitors on alergy therapy will be significant, if these compounds have an antiinflammatory effect within their mechanism. The area with possibly the most promise is selective inhibitors of phosphodiesterase enzymes (PDEs). Selective inhibitors of three isoenzymes of PDEs (PDE III, IV and V) may be possess both activity; bronchodilatory and anti-inflammatory effects. This results imply that this agents may lead to a re-examination and further subclassification of various types of asthma diseases.
Source:
Arhiv za farmaciju, 2002, 52, 1-2, 41-54
Publisher:
  • Savez farmaceutskih udruženja Srbije, Beograd

ISSN: 0004-1963

[ Google Scholar ]
Handle
https://hdl.handle.net/21.15107/rcub_farfar_377
URI
https://farfar.pharmacy.bg.ac.rs/handle/123456789/377
Collections
  • Radovi istraživača / Researchers’ publications
Institution/Community
Pharmacy
TY  - JOUR
AU  - Vladimirov, Sote
AU  - Agbaba, Danica
PY  - 2002
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/377
AB  - Many novel types of asthma therapeutic procedures have been investigated in the past decade. A vast amount of work in the 5-LO inhibitor and LT1-receptor antagonist area has resulted in a various of compounds being identified for clinical trails, and several compounds are used in the clinic. The impact of the LT1-receptor antagonist and 5-LO inhibitors on alergy therapy will be significant, if these compounds have an antiinflammatory effect within their mechanism. The area with possibly the most promise is selective inhibitors of phosphodiesterase enzymes (PDEs). Selective inhibitors of three isoenzymes of PDEs (PDE III, IV and V) may be possess both activity; bronchodilatory and anti-inflammatory effects. This results imply that this agents may lead to a re-examination and further subclassification of various types of asthma diseases.
PB  - Savez farmaceutskih udruženja Srbije, Beograd
T2  - Arhiv za farmaciju
T1  - Eikozanoidi u terapiji astme
VL  - 52
IS  - 1-2
SP  - 41
EP  - 54
UR  - https://hdl.handle.net/21.15107/rcub_farfar_377
ER  - 
@article{
author = "Vladimirov, Sote and Agbaba, Danica",
year = "2002",
abstract = "Many novel types of asthma therapeutic procedures have been investigated in the past decade. A vast amount of work in the 5-LO inhibitor and LT1-receptor antagonist area has resulted in a various of compounds being identified for clinical trails, and several compounds are used in the clinic. The impact of the LT1-receptor antagonist and 5-LO inhibitors on alergy therapy will be significant, if these compounds have an antiinflammatory effect within their mechanism. The area with possibly the most promise is selective inhibitors of phosphodiesterase enzymes (PDEs). Selective inhibitors of three isoenzymes of PDEs (PDE III, IV and V) may be possess both activity; bronchodilatory and anti-inflammatory effects. This results imply that this agents may lead to a re-examination and further subclassification of various types of asthma diseases.",
publisher = "Savez farmaceutskih udruženja Srbije, Beograd",
journal = "Arhiv za farmaciju",
title = "Eikozanoidi u terapiji astme",
volume = "52",
number = "1-2",
pages = "41-54",
url = "https://hdl.handle.net/21.15107/rcub_farfar_377"
}
Vladimirov, S.,& Agbaba, D.. (2002). Eikozanoidi u terapiji astme. in Arhiv za farmaciju
Savez farmaceutskih udruženja Srbije, Beograd., 52(1-2), 41-54.
https://hdl.handle.net/21.15107/rcub_farfar_377
Vladimirov S, Agbaba D. Eikozanoidi u terapiji astme. in Arhiv za farmaciju. 2002;52(1-2):41-54.
https://hdl.handle.net/21.15107/rcub_farfar_377 .
Vladimirov, Sote, Agbaba, Danica, "Eikozanoidi u terapiji astme" in Arhiv za farmaciju, 52, no. 1-2 (2002):41-54,
https://hdl.handle.net/21.15107/rcub_farfar_377 .

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB